Company / Free Cash Flow per Share
Jazz Pharmaceuticals Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$21.39
FY2025
5-year range
$13.11 / $21.81
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
#4 of 192
Health Care
What the data says
Among 192 Health Care companies, Jazz Pharmaceuticals is in the top 2% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $6.06 in FY2016 to $21.81 in FY2024.
Based on SEC 10-K filings.
21.39 in FY2025 with a 5-year CAGR of +9.1%. Top quartile in the Health Care sector.
Improved from $16.90 to $21.39 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- +9.1%
- 10-Year CAGR
- -
Sector benchmark
+544.6% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 1.9% year-over-year.
- Ranks #4 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.39 | -1.9% |
| FY2024 | $21.81 | +29.1% |
| FY2023 | $16.90 | +17.7% |
| FY2022 | $14.35 | +9.5% |
| FY2021 | $13.11 | -5.5% |
| FY2020 | $13.87 | +20.5% |
| FY2019 | $11.51 | +16.3% |
| FY2018 | $9.89 | -10.9% |
| FY2017 | $11.10 | +83.3% |
| FY2016 | $6.06 | -26.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026